Page last updated: 2024-11-08

chloramphenicol and Hypertension, Portal

chloramphenicol has been researched along with Hypertension, Portal in 2 studies

Amphenicol: Chloramphenicol and its derivatives.

Hypertension, Portal: Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN.

Research Excerpts

ExcerptRelevanceReference
" The half-life of chloramphenicol (t 1/2) was increased in the various liver disorders, the metabolic clearance rate (MCR) and apparent volume of distribution (Vd) were decreased and the area under the time - concentrations curve (AUC) showed an increase."1.26Pharmacokinetic study of chloramphenicol in patients with liver disease. ( Datta, DV; Mathur, VS; Narang, AP; Nath, N, 1981)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Narang, AP1
Datta, DV1
Nath, N1
Mathur, VS1
Erlinger, S1
Sakellaridis, DA1
Maillard, JN1
Benhamou, JP1

Other Studies

2 other studies available for chloramphenicol and Hypertension, Portal

ArticleYear
Pharmacokinetic study of chloramphenicol in patients with liver disease.
    European journal of clinical pharmacology, 1981, Volume: 20, Issue:6

    Topics: Acute Disease; Adult; Budd-Chiari Syndrome; Chloramphenicol; Female; Half-Life; Hepatitis; Humans; H

1981
[The angiocholitic forms of the congenital hepatic fibrosis].
    La Presse medicale, 1969, Jul-12, Volume: 77, Issue:34

    Topics: Adolescent; Adult; Ampulla of Vater; Biliary Tract Diseases; Chloramphenicol; Cholangiography; Chola

1969